Pharmaceutical companies' policies and practices regarding prospective registration of dermatology-related clinical trials [8]

British Journal of Dermatology

Volumn 155, Issue 3, 2006, Pages 635-638

  Lott, J P ^a   Katz, K A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL STUDY; DERMATOLOGY; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; INTERNET; LETTER; POLICY; PRIORITY JOURNAL; REGISTER; REGISTRATION;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DERMATOLOGY; DRUG INDUSTRY; HUMANS; REGISTRIES;

EID: 33747038340     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07386.x     Document Type: Letter

References (10)

1. Rennie D. Trial registration: a great idea switches from ignored to irresistible. JAMA 2004; 292:1359-62.
2. Steinbrook R. Registration of clinical trials - voluntary or mandatory? N Engl J Med 2004; 351:1820-2.
3. Steinbrook R. Public registration of clinical trials. N Engl J Med 2004; 351:315-17.
4. Drazen JM, Wood AJ. Trial registration report card. N Engl J Med 2005; 353:2809-11.
5. Haug C, Gotzsche PC, Schroeder TV. Registries and registration of clinical trials. N Engl J Med 2005; 353:2811-12.
6. Zarin DA, Tse T, Ide NC. Trial registration at clinicaltrials.gov between May and October 2005. N Engl J Med 2005; 353:2779-87.
7. DeAngelis CD, Drazen JM, Frizelle FA et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004; 292:1363-4.
8. DeAngelis CD, Drazen JM, Frizelle FA et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. JAMA 2005; 293:2927-9.
9. Pharmaceutical Research and Manufacturers of America [home page on the Internet]. PhRMA Clinical Trial Registry Proposal [about three screens]. Washington, DC: PhRMA, c. 2002-5 [cited 6 January 2005]. (http://www.phrma.org/ publications/policy/06.01.2005.1111.cfm).
10. International Federation of Pharmaceutical Manufacturers & Associations. Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases. Geneva: IFPMA, 2005 [cited 10 February 2006]. (http://www.ifpma.org/clinicaltrials.html).